Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Custom Research Competitive Landscape Industry News FAQ
On This Report

Anesthesia and Respiratory Devices Market Size & Growth Forecast 2027–2036, By Segments (Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 5263| Published Date: Jun-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Anesthesia and Respiratory Devices Market size stood at USD 60.5 billion in 2026 and is predicted to grow at a 5.32% CAGR from 2027 to 2036, attaining USD 101.59 billion by 2036. The industry revenue for 2027 is calculated at USD 63.21 billion.

Base Year Value (2026)
USD 60.5 billion
CAGR (2027-2036)
5.32%
Forecast Year Value (2036)
USD 101.59 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Anesthesia and Respiratory Devices Market Intelligence Snapshot

Regional Market Dynamics

  • North America holds 32.33% share due to mature hospital infrastructure, broad installed base of devices, and steady demand from surgical and critical care applications.
  • Asia Pacific’s 6.78% CAGR is driven by hospital expansion, rising surgical access, and increasing deployment of respiratory support equipment across growing healthcare networks.

Segment Momentum

  • Respiratory Devices held a 63% market share in 2026 due to their essential role in acute care, critical care, and long-term respiratory management across a broad range of patient conditions.
  • Respiratory Devices are also the fastest-growing segment because their routine clinical use, broad application range, and ongoing demand for breathing support sustain strong adoption across healthcare settings.

Market Expansion Drivers

  • Rising COPD and sleep apnea prevalence increasing long-term respiratory therapy device utilization.
  • Advancements in connected anesthesia workstations improving surgical safety and clinical workflow efficiency.
  • Expanding homecare respiratory monitoring adoption accelerating demand for portable oxygen and humidification systems.

Leading Market Participants

  • Major players in the anesthesia and respiratory devices market include Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Drägerwerk AG & Co. KGaA (Germany), Fisher & Paykel Healthcare Corporation Limited (New Zealand), ResMed Inc. (United States), Teleflex Incorporated (United States), Getinge AB (Sweden), Masimo Corporation (United States), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 60.5 billion
  • 2027 Estimated Market Size: USD 63.21 billion.
  • Projected Market Size: USD 101.59 billion by 2036
  • Growth Forecast: 5.32% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Respiratory Devices (Product)
  • Emerging Opportunity Segment: Respiratory Devices (Product)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising COPD and sleep apnea prevalence increasing long-term respiratory therapy device utilization

The anesthesia and respiratory devices market is supported by the growing prevalence of chronic respiratory conditions such as COPD and sleep apnea, which increases the need for sustained respiratory management and monitoring. Patients with long-term breathing disorders may require oxygen therapy, respiratory support, humidification, and monitoring equipment depending on the severity and progression of their conditions. Continued clinical management of these disorders is therefore creating demand for respiratory devices across hospitals, specialized care settings, and long-term treatment environments.

Advancements in connected anesthesia workstations improving surgical safety and clinical workflow efficiency

Advancements in connected anesthesia workstations are driving the anesthesia and respiratory devices market by integrating monitoring, ventilation, and anesthesia delivery functions into increasingly coordinated clinical systems. Connected workstations can provide anesthesia professionals with more comprehensive visibility into patient respiratory and physiological parameters during procedures, supporting timely adjustments to therapy. Digital connectivity also enables improved access to procedural information and more organized workflows, helping clinical teams manage anesthesia delivery and patient monitoring within complex surgical environments.

Expanding homecare respiratory monitoring adoption accelerating demand for portable oxygen and humidification systems

Expansion of home-based respiratory monitoring will boost the anesthesia and respiratory devices market as patients with ongoing respiratory care requirements increasingly receive treatment and monitoring outside traditional healthcare facilities. Portable oxygen systems and humidification devices can support patients who require respiratory assistance while allowing greater flexibility in daily activities and home-based care. The shift toward decentralized healthcare delivery is also encouraging the use of compact equipment that can be operated in residential environments and incorporated into longer-term respiratory management programs.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising COPD and sleep apnea prevalence increasing long-term respiratory therapy device utilization 2.00% Moderate North America, Europe High Near Term
Advancements in connected anesthesia workstations improving surgical safety and clinical workflow efficiency 1.80% High North America, Asia Pacific High Mid Term
Expanding homecare respiratory monitoring adoption accelerating demand for portable oxygen and humidification systems 1.40% Moderate Asia Pacific, North America Emerging Mid Term

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Anesthesia and Respiratory Devices Market
Largest Region
North America
32.33% Market Share in 2026

North America (Largest Region)

North America dominated the anesthesia and respiratory devices market, accounting for a 32.33% share in 2026, supported by advanced hospital infrastructure, high utilization of sophisticated medical equipment, and strong demand for reliable respiratory and anesthesia care. The region's established surgical and critical-care capabilities encourage continuous adoption of technologically advanced devices, while growing attention to patient monitoring, respiratory management, and procedural safety supports sustained demand. Healthcare providers are also increasingly focused on improving clinical efficiency and maintaining high standards of care, reinforcing the use of modern anesthesia and respiratory technologies.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is expected to register the fastest market expansion, fueled by healthcare infrastructure development, rising demand for surgical and critical-care services, and increasing investment in modern medical equipment. Improvements in hospital capacity and greater access to specialized healthcare are creating opportunities for anesthesia and respiratory device adoption, while growing awareness of advanced patient-care technologies is encouraging healthcare facilities to upgrade existing systems. The region's evolving healthcare landscape and continued emphasis on strengthening clinical capabilities provide a favorable foundation for further market development.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
🔒 Need data on a specific country or region?. Individual country/region reports are available at discounted pricing. Inquire Before Buying
Country Insights

Key Country Insights

Germany 🇩🇪

Precision Surgical Support

Germany emphasizes anesthesia and respiratory devices that deliver reliable clinical performance and compatibility with sophisticated hospital infrastructure. Healthcare facilities in Germany continue upgrading systems that enhance perioperative care and respiratory management.

France 🇫🇷

Perioperative Care Enhancement

France invests in anesthesia and respiratory devices that improve patient monitoring, procedural safety, and respiratory support across healthcare facilities. French hospitals continue adopting technologies that reinforce consistent perioperative care and intensive care services.

Italy 🇮🇹

Hospital Equipment Modernization

Italy is modernizing anesthesia and respiratory device infrastructure through replacement of legacy systems and broader adoption of advanced respiratory support technologies. Healthcare providers in Italy focus on improving equipment reliability and clinical workflow across surgical departments.

Japan 🇯🇵

Respiratory Care Continuity

Japan focuses on anesthesia and respiratory devices that support surgical care alongside long-term respiratory disease management. Healthcare institutions in Japan continue expanding the use of advanced respiratory technologies to improve treatment quality and patient monitoring.

South Korea 🇰🇷

Integrated Hospital Technology

South Korea continues strengthening anesthesia and respiratory care through digitally integrated medical equipment and advanced monitoring capabilities. Hospitals across South Korea prioritize technologies that improve clinical efficiency during surgery and critical care treatment.

United States 🇺🇸

Critical Care Advancement

The U.S. anesthesia and respiratory devices market prioritizes advanced monitoring, ventilatory support, and integrated operating room technologies. Healthcare providers in the U.S. continue investing in equipment that improves patient safety across surgical and intensive care settings.

Segment Analysis

Segment Leadership and Growth Trends

Anesthesia and Respiratory Devices Market Share (%), by Product, 2026

Respiratory Devices
Anesthesia Devices

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Product Segment Analysis: Respiratory Devices (Largest & Fastest-Growing Segment)

Respiratory devices segment dominated the anesthesia and respiratory devices market in 2026, accounting for a 63% share, and is also projected to be the fastest-growing product segment. Its strong position reflects the essential role of respiratory equipment in supporting ventilation, oxygen delivery, airway management, and respiratory monitoring across hospital and critical-care environments. Demand is reinforced by the continuing need to manage acute and chronic respiratory conditions, surgical procedures requiring assisted ventilation, and patients requiring intensive respiratory support. Ongoing improvements in device portability, monitoring capabilities, connectivity, and clinical functionality are further encouraging healthcare providers to adopt advanced respiratory technologies.

Segment Sub-Segment Largest Segment Fastest Growing
Product Respiratory Devices, Anesthesia Devices Respiratory Devices Respiratory Devices
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

Prominent players in the anesthesia and respiratory devices market:

1. Medtronic plc (Ireland)

2. Koninklijke Philips N.V. (Netherlands)

3. GE HealthCare Technologies Inc. (United States)

4. Drägerwerk AG & Co. KGaA (Germany)

5. Fisher & Paykel Healthcare Corporation Limited (New Zealand)

6. ResMed Inc. (United States)

7. Teleflex Incorporated (United States)

8. Getinge AB (Sweden)

9. Masimo Corporation (United States)

10. Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China)

The anesthesia and respiratory devices market is experiencing strong innovation driven by growing demand for precision respiratory support and advanced patient monitoring systems. Industry participants are enhancing ventilator efficiency, anesthesia delivery accuracy, and portable respiratory care technologies to improve clinical outcomes. Increasing investment in intelligent monitoring and automated therapy systems is also reshaping competitive dynamics within the market.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Medtronic plc (Ireland)
Koninklijke Philips N.V. (Netherlands)
GE HealthCare Technologies Inc. (United States)
Drägerwerk AG & Co. KGaA (Germany)
Fisher & Paykel Healthcare Corporation Limited (New Zealand)
ResMed Inc. (United States)
Teleflex Incorporated (United States)
Getinge AB (Sweden)
Masimo Corporation (United States)
Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Masimo May-24 Masimo partnered with Medable Inc. to integrate its MightySat Rx pulse oximeter into a large-scale clinical research platform. Used across eight major oncology trials involving over 3,000 patients, this integration demonstrates the utility of high-sensitivity, medical-grade wearable respiratory monitoring in clinical evidence generation, highlighting the shift toward remote patient-centric data collection in respiratory care.
Royal Philips Apr-24 Royal Philips initiated the expansion of its Healthcare Innovation Center in Maharashtra, India. The new R&D facility is dedicated to advancing technologies in sleep and respiratory care, precision diagnosis, and patient monitoring, reflecting a strategic move to localize innovation and enhance global R&D capabilities for respiratory and therapeutic device product pipelines.
Medtronic Jun-22 Medtronic and GE Healthcare received regulatory clearance for the integration of Microstream capnography and INVOS regional oximetry into the CARESCAPE monitoring platform. This technological collaboration enhances real-time monitoring of respiratory compromise and perioperative complications, offering clinicians advanced analytical tools to improve patient safety and monitoring precision in high-acuity respiratory and anesthesia clinical settings.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Anesthesia and Respiratory Devices Market — Custom Segments

Segment Sub-Segment
Clinical Application Surgical Anesthesia, Critical Care & Intensive Care, Emergency & Transport Care, Chronic Respiratory Care, Sleep-Disordered Breathing Management, Home Respiratory Care
Portability Stationary Devices, Portable Devices, Handheld Devices
Patient Age Group Neonatal, Pediatric, Adult, Geriatric

Anesthesia and Respiratory Devices Market — Custom TOC

Custom Chapter Chapter Details
Hospital Capital Equipment Investment Outlook
  • Capital Investment Priorities Across Hospital Care Areas
  • Equipment Budget Allocation and Investment Drivers
  • Replacement Versus Capacity-Expansion Investment
  • Procurement Timing and Investment Cycle Dynamics
Installed Base Modernization and Replacement Opportunity
  • Installed Equipment Age and Modernization Requirements
  • Replacement Triggers and Upgrade Priorities
  • Technology Obsolescence and Performance Gaps
  • Modernization Opportunity by Care Environment
  • Replacement Demand Outlook and Priority Opportunities
Care Setting Migration and Equipment Demand Outlook
  • Shifts in Acute, Critical, and Ambulatory Care Delivery
  • Migration of Anesthesia and Respiratory Procedures Across Settings
  • Care Model Changes and Equipment Requirements
  • Emerging Demand Pockets Across Non-Hospital Settings

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

What is the current size of the anesthesia and respiratory devices market?

The market size of the anesthesia and respiratory devices is estimated at USD 63.21 billion in 2027.

What are the growth projections for the anesthesia and respiratory devices industry?

Anesthesia and Respiratory Devices Market size stood at USD 60.5 billion in 2026 and is predicted to grow at a 5.32% CAGR from 2027 to 2036, attaining USD 101.59 billion by 2036.

How is the shift toward long-term respiratory care influencing demand in the anesthesia and respiratory devices market?

Growing prevalence of COPD and sleep apnea is increasing demand for reliable long-term respiratory therapy devices, encouraging broader deployment across hospitals, sleep centers, and homecare while reinforcing recurring replacement demand for therapy components.

How are connected technologies and homecare trends shaping investment priorities in the anesthesia and respiratory devices market?

Healthcare providers are investing in connected anesthesia workstations and portable home respiratory devices to improve clinical workflow, support remote patient monitoring, enhance interoperability, and expand care delivery beyond traditional healthcare facilities.

Why do respiratory devices dominate the anesthesia and respiratory devices market?

Respiratory Devices held a 63% market share in 2026 due to their essential role in acute care, critical care, and long-term respiratory management across a broad range of patient conditions.

What is supporting the continued growth of respiratory devices in the anesthesia and respiratory devices market?

Respiratory Devices are also the fastest-growing segment because their routine clinical use, broad application range, and ongoing demand for breathing support sustain strong adoption across healthcare settings.

Why does North America lead the anesthesia and respiratory devices market?

North America holds 32.33% share due to mature hospital infrastructure, broad installed base of devices, and steady demand from surgical and critical care applications.

What is driving fastest growth in Asia Pacific anesthesia and respiratory devices market?

Asia Pacific’s 6.78% CAGR is driven by hospital expansion, rising surgical access, and increasing deployment of respiratory support equipment across growing healthcare networks.

Who are the leading players in the anesthesia and respiratory devices landscape?

Major players in the anesthesia and respiratory devices market include Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Drägerwerk AG & Co. KGaA (Germany), Fisher & Paykel Healthcare Corporation Limited (New Zealand), ResMed Inc. (United States), Teleflex Incorporated (United States), Getinge AB (Sweden), Masimo Corporation (United States), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Read our Research Approach →

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →